Literature DB >> 31762438

H1-Antihistamines May No Longer Be Necessary for Patients With Refractory Chronic Spontaneous Urticaria After Initiation of Omalizumab.

L F Ensina1,2, L K Arruda3, R A Campos4, R F Criado5, S Rodrigues Valle6, J Ml Melo3, J Cs Oliveira4, Jr Sd Dortas6, A P Cusato-Ensina1, I C Camelo-Nunes2, R C Agondi7.   

Abstract

Entities:  

Keywords:  Histamine antagonists; Omalizumab; Therapeutics; Urticaria

Year:  2019        PMID： 31762438     DOI： 10.18176/jiaci.0464

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  1 in total

1.  Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Authors:  Elizabeth García-Gómez; Edgardo Chapman; María Beatriz García-Paba; Jaime Ocampo-Gómez; Eduardo Egea-Bermejo; Gloria Garavito-De Egea; Luis Fang; Mauricio Sarrazola; Jorge Mario Sánchez-Caraballo; Carlos Serrano-Reyes; Diana Lucia Silva-Espinosa; Dolly Vanessa Rojas-Mejía; Sergio M Moreno
Journal:  Front Allergy       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.